Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma?Masakazu Yamamoto, Masayuki Nakano, Ken Takasaki et al.|Journal of Surgical Oncology|1998Cited by 127
Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in JapanMasahiko Tomimatsu, Masayuki Nakano, Ken Takasaki et al.|Cancer|1993Cited by 110
Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma.Hiroaki Okuda, Masayuki Nakano, Masakazu Yamamoto et al.|PubMed|2000Cited by 90
Correlation between expression of MUC1 core protein and outcome after surgery in mass‐forming intrahepatic cholangiocarcinomaNaoki Matsumura, Masayuki Nakano, Ken Takasaki et al.|Cancer|2002Cited by 78
Serum levels of des-?-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinomaHiroaki Okuda, Masayuki Nakano, Toshimi Nakanishi et al.|Cancer|2000Cited by 73